TABLE 1.
Effect of human serum on the CD14-dependent inhibition of DV infection of MO/Mφ by LPSa
| Expt no. | Virus titer in PFU/ml (% inhibition) with (+) or without (−):
|
|||||||
|---|---|---|---|---|---|---|---|---|
| −ΔAHS
|
+ΔAHS
|
|||||||
| −LPS | +LPS | +MY4, +LPS | +MoS3, +LPS | −LPS | +LPS | +MY4, +LPS | +MoS39, +LPS | |
| 1 | 2.31 × 105 | 8.46 × 104 (63.4) | 2.20 × 105 (4.7) | 2.46 × 105 (−6.5) | 6.53 × 104 | 3.50 × 103 (94.6) | 5.07 × 104 (22.4) | 6.67 × 104 (−2.1) |
| 2 | 2.74 × 105 | 9.23 × 104 (66.3) | 2.43 × 105 (11.2) | ND | 1.14 × 105 | 1.03 × 104 (90.9) | 1.21 × 105 (−6.1) | ND |
Seven-day-old primary human MO/Mφ obtained from two different donors (i.e., experiments 1 and 2) were used. The cells were infected with DV at an MOI of 3 PFU per cell. Viral adsorption was performed in serum-free α-MEM (−ΔAHS) or α-MEM containing 3% ΔAHS (+ΔAHS), either with or without 5 μg of LPS per ml (+LPS and −LPS, respectively) for 2.5 h. Before coincubation of LPS and DV, some cultures were pretreated overnight with 20 μg of MY4 per ml (+MY4) or 30 μg of MoS39 (+MoS39) per ml. After 44 h of infection, culture supernatants were harvested and assayed to determine the infectious-DV titers. ND, not determined.